Systematic Review of the Cost-Effectiveness of Transcatheter Aortic Valve Implantation
Transcatheter aortic valve implantation (TAVI) has emerged as an alternative treatment to aortic valve replacement (AVR) for selected patients with severe aortic stenosis. The present systematic review was conducted to analyze the cost-effectiveness of this novel technique within reimbursed healthcare systems.
Transcatheter Aortic Valve Implantation: Patient Selection
This review will familiarize the reader with the concepts of the interdisciplinary Heart team, risk scores as well as the most important imaging algorithms suited to select appropriate TAVI patients.
Basic Data From 176 Studies on the Immediate Outcome After Aortic Valve Replacement With or Without Coronary Artery Bypass Surgery
The aim of this study was to summarize the immediate outcome after aortic valve replacement (AVR) with or without coronary artery bypass grafting (CABG).
Current Concepts for Minimally Invasive Mitral Valve Repair
The excellent results of minimally invasive mitral valve repair must be considered whenever already available or any new transcatheter techniques are offered.
Minimally Invasive Mitral Valve Reconstruction on the Fibrillating Heart for High-Risk Patients
Mitral valve surgery after previous cardiac surgery is technically demanding and risky. In patients after coronary artery bypass grafting (CABG), mitral valve surgery is associated with a high risk of injury to the bypass graft with concomitant myocardial ischemia.
Minimally Invasive Mitral Valve Procedures: The Current State
In this paper, the authors attempt to focus on the evolution, techniques, results, and the future perspective of minimally invasive mitral valve surgery (MIMVS).
Retrograde Femoral Arterial Perfusion and Stroke Risk During Minimally Invasive Mitral Valve Surgery: Is There Cause for Concern
Recent data have suggested that retrograde arterial perfusion (RAP) during minimally invasive mitral valve surgery (MIMVS) is associated with a higher stroke rate than sternotomy approaches.
Baxter Initiates Worldwide Voluntary Recall Of Select Lots Of 5 percent Dextrose Injection, USP And 0.9 percent Sodium Chloride Injection, USP Intravenous (IV) Solutions
Baxter International Inc. announced today it has initiated a voluntary recall to the hospital/user level of one lot of 5 percent Dextrose Injection, USP and four lots of 0.9 percent Sodium Chloride Injection, USP due to particulate matter found in the solutions. Injecting a product containing particulate matter may result in blockages of blood vessels, which can result in stroke, heart attack or damage to other organs such as the kidney or liver.
Regional Variation in Arterial Saturation and Oxygen Delivery during Venoarterial Extracorporeal Membrane Oxygenation
These results suggest that antegrade cannulation for VA-ECMO improves oxygen delivery to the proximal aorta distribution.
Report from AmSECT’s International Consortium for Evidence-Based Perfusion: American Society of Extracorporeal Technology Standards and Guidelines for Perfusion Practice: 2013
The aim of this report is to describe the method of development and content of AmSECT's new professional standards and guidelines.